PubMed

Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne).

Mandal N, Chisholm IH.

Br J Ophthalmol. 2002 Jan;86(1):118-9. No abstract available. PMID: 11801521 [PubMed - indexed for MEDLINE]Related articlesFree article

Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.

Bessler NM; Vam Study Writing Committee.

Retina. 2004 Aug;24(4):512-20. Erratum in: Retina. 2004 Dec;24(6):990. PMID: 15300071 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2002 Nov;120(11):1443-54.PMID: 12427056 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin (Visudyne) for macular degeneration.

[No authors listed]

Med Lett Drugs Ther. 2000 Sep 4;42(1086):81-2. No abstract available. PMID: 10980812 [PubMed - indexed for MEDLINE]Related articles

Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration.

Frennesson CI, Nilsson SE.

Acta Ophthalmol Scand. 2004 Dec;82(6):645-50.PMID: 15606458 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group.

Retina. 2004 Feb;24(1):1-12.PMID: 15076937 [PubMed - indexed for MEDLINE]Related articles

Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.

Hariprasad SM, Shah GK.

Ophthalmic Surg Lasers Imaging. 2005 May-Jun;36(3):258-60.PMID: 15957487 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.

Verteporfin Roundtable 2000 and 2001 Participants; Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators.

Retina. 2002 Feb;22(1):6-18. Review.PMID: 11884872 [PubMed - indexed for MEDLINE]Related articles

Using light to treat age-related macular degeneration.

Nosek J.

Nurs Times. 2005 Nov 15-21;101(46):30-3.PMID: 16315801 [PubMed - indexed for MEDLINE]Related articles

Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

Rubin GS, Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic therapy (TAP) study group.

Retina. 2002 Oct;22(5):536-44.PMID: 12441717 [PubMed - indexed for MEDLINE]Related articles

Model study of AREDS antioxidant supplementation of AMD compared to Visudyne: a dominant strategy?

Trevithick J, Massel D, Robertson JM, Tomany S, Wall R.

Ophthalmic Epidemiol. 2004 Dec;11(5):337-46.PMID: 15590581 [PubMed - indexed for MEDLINE]Related articles

[Photodynamic therapy with Visudyne in macular degeneration associated with subfoveal classical choroidal neovascularization]

Soucek P, Boguzsaková J, Cihelková I.

Cesk Slov Oftalmol. 2002 Apr;58(2):89-97. Czech. Erratum in: Cesk Slov Oftalmol. 2002 Nov;58(6):403.. PMID: 12046251 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.

Verteporfin Roundtable Participants.

Retina. 2005 Feb-Mar;25(2):119-34. Review.PMID: 15689800 [PubMed - indexed for MEDLINE]Related articles

[Low-vision rehabilitation of age-related macular degeneration patients with retrofoveal choroidal new-vessels treated with photodynamic therapy with verteporfin]

Mauget-Faÿsse M, Dubois E, Quaranta M, Osternaud S, Vettard S.

J Fr Ophtalmol. 2005 Apr;28(4):372-9. French. PMID: 15973197 [PubMed - indexed for MEDLINE]Related articlesFree article

Preserving vision with verteporfin photodynamic therapy.

Yang YC.

Hosp Med. 2004 Jan;65(1):39-43. Review.PMID: 14964795 [PubMed - indexed for MEDLINE]Related articles

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Blinder KJ, Bradley S, Bressler NM, Bressler SB, Donati G, Hao Y, Ma C, Menchini U, Miller J, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Strong HA, Stur M, Su XY, Virgili G; Treatment of Age-related Macular Degeneration with Photodynamic Therapy study group; Verteporfin in Photodynamic Therapy study group.

Am J Ophthalmol. 2003 Sep;136(3):407-18.PMID: 12967792 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

Arch Ophthalmol. 2005 Apr;123(4):448-57.PMID: 15824216 [PubMed - indexed for MEDLINE]Related articles

Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Japanese Age-Related Macular Degeneration Tial (JAT) Study Group.

Am J Ophthalmol. 2003 Dec;136(6):1049-61.PMID: 14644215 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Monés JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M, Singerman LJ, Slakter JS, Strong A, Vannier S; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2002 Oct;120(10):1307-14.PMID: 12365909 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy for age-related macular degeneration.

Franks W.

Age Ageing. 2002 Jan;31(1):5-6. No abstract available. PMID: 11850299 [PubMed - indexed for MEDLINE]Related articlesFree article